ASXL3 | OmnibusX

Name	Number of supported studies	Average coverage
glutamatergic neuron	12 studies	47% ± 24%	Explore
oligodendrocyte precursor cell	9 studies	29% ± 10%	Explore
GABAergic neuron	8 studies	48% ± 19%	Explore
interneuron	6 studies	54% ± 17%	Explore
oligodendrocyte	6 studies	25% ± 11%	Explore
neuron	4 studies	42% ± 17%	Explore
astrocyte	4 studies	33% ± 13%	Explore
GABAergic interneuron	3 studies	44% ± 20%	Explore
GABAergic amacrine cell	3 studies	46% ± 16%	Explore
amacrine cell	3 studies	32% ± 10%	Explore
glycinergic amacrine cell	3 studies	33% ± 14%	Explore

Name	Number of supported studies	Average coverage
brain	13 studies	37% ± 19%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
brain	86%	367.91	2273 / 2642	82%	3.34	581 / 705
kidney	100%	350.36	89 / 89	54%	1.13	489 / 901
thymus	100%	692.07	652 / 653	18%	0.42	111 / 605
prostate	99%	446.60	242 / 245	11%	0.16	55 / 502
ovary	100%	1148.17	180 / 180	9%	0.23	40 / 430
pancreas	87%	138.55	284 / 328	20%	0.61	36 / 178
uterus	93%	331.87	158 / 170	13%	0.39	59 / 459
intestine	99%	367.21	956 / 966	6%	0.10	34 / 527
bladder	100%	395.00	21 / 21	4%	0.18	22 / 504
stomach	100%	382.76	358 / 359	3%	0.07	9 / 286
lung	93%	168.95	540 / 578	6%	0.28	75 / 1155
blood vessel	100%	358.26	1331 / 1335	0%	0	0 / 0
breast	90%	170.87	413 / 459	4%	0.12	46 / 1118
heart	90%	233.39	774 / 861	0%	0	0 / 0
adipose	84%	159.79	1006 / 1204	0%	0	0 / 0
liver	81%	143.54	184 / 226	0%	0.01	2 / 406
esophagus	55%	80.03	788 / 1445	3%	0.05	5 / 183
spleen	38%	46.48	92 / 241	0%	0	0 / 0
skin	25%	31.65	456 / 1809	1%	0.03	4 / 472
adrenal gland	4%	5.41	11 / 258	3%	0.03	6 / 230
eye	0%	0	0 / 0	5%	0.09	4 / 80
lymph node	0%	0	0 / 0	3%	0.04	1 / 29
muscle	1%	1.20	9 / 803	0%	0	0 / 0
peripheral blood	0%	0.08	1 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
tonsil	0%	0	0 / 0	0%	0	0 / 45
ureter	0%	0	0 / 0	0%	0	0 / 1

GO_0051055	Biological process	negative regulation of lipid biosynthetic process
GO_0045944	Biological process	positive regulation of transcription by RNA polymerase II
GO_0009887	Biological process	animal organ morphogenesis
GO_0035517	Cellular component	PR-DUB complex
GO_0003677	Molecular function	DNA binding
GO_0042975	Molecular function	peroxisome proliferator activated receptor binding
GO_0003682	Molecular function	chromatin binding
GO_0046872	Molecular function	metal ion binding

Gene name	ASXL3
Protein name	Putative Polycomb group protein ASXL3 (Additional sex combs-like protein 3) ASXL transcriptional regulator 3
Synonyms	KIAA1713
Description	FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. PcG proteins are not required to initiate repression, but to maintain it during later stages of development. They probably act via methylation of histones, rendering chromatin heritably changed in its expressibility (By similarity). .
Accessions	K7EMU6 ENST00000642541.1 Q9C0F0 ENST00000593195.6 ENST00000681521.1 A0A8V8TKV8 ENST00000592541.6 ENST00000592288.6 K7ELG8 ENST00000696964.1 A0A7P0TAE5 K7EJ76 A0A2R8Y461 ENST00000269197.12 [Q9C0F0-1]

ASXL3 report